Cetera Investment Advisers
DMK

Cetera Investment Advisers’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Cetera Investment Advisers’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-146
Closed -$2K – 2182
2022
Q3 		$2K Hold
146
– – ﹤0.01% 1697
2022
Q2 		$5K Hold
146
– – ﹤0.01% 1809
2022
Q1 		$6K Hold
146
– – ﹤0.01% 1859
2021
Q4 		$6K Buy
+146
New +$9.11K ﹤0.01% 1850

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cetera Investment Advisers's DMK Position: Q4 2022 in Review

Cetera Investment Advisers sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2022, closing a stake of 146 shares — an estimated $2K sold.

Cetera Investment Advisers first reported a position in DMK in Q4 2021 and held it in 4 quarters. The position peaked at $6K in Q1 2022. 48 funds tracked by Wall St. Rank hold DMK as of Q4 2022.

  • Cetera Investment Advisers reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2022 after selling out during the quarter.
  • Cetera Investment Advisers sold 146 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2022, an estimated $2K.
  • Cetera Investment Advisers first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2021 and held it in 4 quarters.
  • Cetera Investment Advisers's DMK Pharmaceuticals Corporation Common Stock position peaked at $6K in Q1 2022.
  • 48 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2022.

Based on Cetera Investment Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.